Hui Zeng
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology
- Hematology top 5%
- Immunology
- Co-authors
- Juan DuXiaofang WangKristen Martins‐TaylorTianming ZhaoKevin G. OttoFangping ChenLiqing JinC. Anthony Blau
- Topics
- Acute Myeloid Leukemia Research (15 papers)RNA modifications and cancer (11 papers)Epigenetics and DNA Methylation (9 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Zeng
77 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 929
- Cancer Research 324
- Oncology 228
- Hematology 154
- Immunology 140
Countries citing papers authored by Hui Zeng
This map shows the geographic impact of Hui Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Zeng more than expected).
Fields of papers citing papers by Hui Zeng
This network shows the impact of papers produced by Hui Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Zeng. The network helps show where Hui Zeng may publish in the future.
Co-authorship network of co-authors of Hui Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Zeng. A scholar is included among the top collaborators of Hui Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Zeng. Hui Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 67 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 8 | |
| 10 | 18 | |
| 11 | 10 | |
| 12 | 19 | |
| 13 | 13 | |
| 14 | 8 | |
| 15 | 23 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 5 | |
| 19 | 4 | |
| 20 | 19 |
About Hui Zeng
Hui Zeng is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Cancer Research (324 citations), Hematology (154 citations) and Molecular Biology (929 citations). Hui Zeng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Juan Du, Xiaofang Wang, Kristen Martins‐Taylor, Tianming Zhao, Kevin G. Otto, Fangping Chen, Liqing Jin, C. Anthony Blau, Min Guo and Ren‐He Xu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.